Analyst Ratings for Diebold Nixdorf Inc. (DBD)

Updated: 2017-07-27

Shares of Diebold Nixdorf Inc. (NYSE:DBD) have received a consensus rating of Overweight from Wall Street analysts. About 30 days ago, DBD was issued an average rating of Overweight.

Of the 9 analysts covering the stock, 6 gave it a buy rating, 0 gave an overweight rating, 3 issued a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.

DBD was given price targets by several analysts. The highest price target was 32, implying potential capital gains of 38.83 percent. The lowest price target was 26, implying potential capital losses of 12.8 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

In the last 30 days, analysts have changed their quarterly earnings estimates downwards by an average of -75 percent. That number becomes -75 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed downwards by -37.68 percent. If we look at the last 90 days instead, we find a net average change of -37.87 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 3 analysts revised their estimates downwards. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 3 analysts that revised their FY estimates downwards.

DBD has a 52-week high of 31.85 and a 52-week low of 19.95. Today's price is 15.54 percent above the 52-week low, and 27.63 percent lower than its 52-week high. DBD has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The DBD value stock report compares DBD to some of its peers using value stock charts. The market cap of DBD is $1.72 billion. DBD is estimated to release their earnings results for the quarter on 0000-00-00, days from today.